Publication | Closed Access
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
342
Citations
23
References
2014
Year
In this study, brivanib as adjuvant therapy to TACE did not improve OS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1